Score | Rheumatoid arthritis | Ankylosing spondylitis | Psoriatic arthritis | Psoriasis | Other a | Total |
---|---|---|---|---|---|---|
CGI-Severity | Â | Â | Â | Â | Â | Â |
N [N missing] | 190 [1] | 43 [0] | 42 [2] | 35 [0] | 19 [12] | 329 [15] |
Extremely ill | 19 (10.0%) | 0 (0.0%) | 3 (7.1%) | 5 (14.3%) | 4 (21.1%) | 31 (9.4%) |
Severely ill | 39 (20.5%) | 15 (34.9%) | 3 (7.1%) | 8 (22.9%) | 4 (21.1%) | 69 (20.9%) |
Markedly ill | 66 (34.7%) | 18 (41.9%) | 17 (40.5%) | 10 (28.6%) | 3 (15.8%) | 114 (34.7%) |
Moderately ill | 45 (23.7%) | 7 (16.3%) | 14 (33.3%) | 5 (14.3%) | 4 (21.1%) | 75 (22.8%) |
Mildly ill | 13 (6.8%) | 3 (7.0%) | 3 (7.1%) | 4 (11.4%) | 2 (10.5%) | 25 (7.6%) |
Borderline | 4 (2.1%) | 0 (0.0%) | 2 (4.8%) | 3 (8.6%) | 1 (5.3%) | 10 (3.0%) |
Normal | 4 (2.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (5.3%) | 5 (1.5%) |
Mean (SD) b | 3.12 (1.28) | 2.95 (0.90) | 3.40 (1.13) | 3.11 (1.49) | 3.16 (1.77) | Â |
EQ VAS | Â | Â | Â | Â | Â | Â |
N [N missing] | 85 [106] | 22 [21] | 25 [19] | 21 [14] | 6 [25] | 159 [185] |
Mean (SD) b | 49.5 (22.4) | 42.2 (23.8) | 45.6 (19.2) | 50.7 (25.6) | 50.5 (30.8) | 48.1 (22.8) |
Range | 8.0-100.0 | 6.0-90.0 | 8.0-85.0 | 5.0-90.0 | 20.0-92.0 | 5.0-100.0 |
EQ-5D Index | Â | Â | Â | Â | Â | Â |
N [N missing] | 181 [10] | 43 [0] | 43 [1] | 34 [1] | 18 [13] | 319 [25] |
Mean (SD) c | 0.40 (0.34) | 0.37 (0.37) | 0.42 (0.32) | 0.52 (0.39) | 0.51 (0.40) | 0.42 (0.35) |
Range | -0.24-1.00 | -0.24-1.00 | -0.24-0.80 | -0.48-1.00 | -0.35-1.00 | -0.48-1.00 |
Disease specific | HAQ Score | Â | Â | DLQI Score | CHAQ Score | Â |
N [N missing] | 190 [1] | - | - | 35 [0] | 9 [22] | Â |
Mean (SD) | 1.74 (0.65) | - | - | 15.0 (7.8) | 1.35 (0.54) | Â |
Range | 0.00-3.00 | - | - | 3.0-30.0 | 0.50-2.25 | Â |
 |  |  |  |  | CHAQ Pain Score |  |
N [N missing] | - | - | - | - | 8 [23] | Â |
Mean (SD) | - | - | - | - | 49.1 (30.1) | Â |
Range | - | - | - | - | 7.0-90.0 | Â |